WebMD Announces Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
SunTrust Upgrades WebMD Health Corp. (WBMD) to Buy
August 3, 2015 8:38 AM EDTSunTrust Robinson Humphrey upgraded WebMD Health Corp. (NASDAQ: WBMD) from Neutral to Buy with a price target of $52.00 (from $50.00).
For an analyst ratings summary and ratings history on WebMD Health Corp.... More
WebMD Health (WBMD) Tops Q2 EPS by 9c; Boosts FY15 Revenue Outlook
July 30, 2015 4:11 PM EDTWebMD Health (NASDAQ: WBMD) reported Q2 EPS of $0.32, $0.09 better than the analyst estimate of $0.23. Revenue for the quarter came in at $148.3 million versus the consensus estimate of $147.13 million.
WebMD Health sees FY2015 revenue of $625-635 million, versus the consensus of $624.2 million.
For... More
